Description
Orgalutran is a prescription medication that plays a vital role in fertility treatment. A fertility specialist may prescribe it for managing ovarian stimulation in assisted reproductive methods, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
Ganirelix, the active ingredient in Orgalutran, works by inhibiting early luteinizing hormone (LH) surges. This is crucial to prevent premature ovulation before eggs are adequately developed. Through this action, Orgalutran ensures precise control over ovulation timing.
Directions
Fertility specialists exclusively prescribe and oversee Orgalutran's usage.
Its dosing and timing are tailored to each patient's unique response to ovarian stimulation, aiming to optimize the success of egg retrieval.
Ingredients
Orgalutran contains ganirelix as its active component. Inactive ingredients comprise glacial acetic acid, mannitol, and water for injection, adjusted to pH 5.0 with acetic acid or sodium hydroxide.
The medication is available as a 250 microgram/0.5 mL solution.
Interactions
Common drug-drug interactions may include:
- Flotufolastat F18
- Gallium Ga 68 PSMA-11
- Indium 111 Capromab Pendetide
- Piflufolastat F18
Cautions
Regular communication with your fertility specialist remains crucial during Orgalutran treatment. They will closely monitor your response and potential side effects to make necessary adjustments. If any side effects occur, even though they are uncommon, informing your healthcare provider is essential.
It's important to avoid Orgalutran if you have a known hypersensitivity to ganirelix or its ingredients. Mention any latex allergies to your doctor, as the packaging might contain latex.
History of kidney or liver disease should be disclosed before starting therapy.
If you become pregnant, discontinue Orgalutran immediately. Common side effects encompass abdominal pain, headache, injection-site reactions, and more.
Side Effects
Common adverse reactions include:
- Abdominal pain
- Anaphylactic shock
- Anaphylaxis
- Angioedema
- Headache
- Hypersensitivity reaction
- Injection-site reaction
- Nausea
- Nonimmune anaphylaxis
- Ovarian hyperstimulation syndrome
- Pelvic pain
- Urticaria
- Vaginal hemorrhage
References
Orgalutran [Patient Medication Information]. Organon; 2021.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 10231